Production (Stage)
PharmaTher Holdings Ltd.
PHRM
CNSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 136.70K | 167.50K | 174.00K | 142.70K | 159.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 244.60K | 236.30K | 234.80K | 283.50K | 308.30K |
| Operating Income | -244.60K | -236.30K | -234.80K | -283.50K | -308.30K |
| Income Before Tax | -258.20K | -267.30K | -277.60K | -264.60K | -270.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -258.20K | -267.30K | -277.60K | -264.60K | -270.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -258.20K | -267.30K | -277.60K | -264.60K | -270.00K |
| EBIT | -244.60K | -236.30K | -234.80K | -283.50K | -308.30K |
| EBITDA | -244.50K | -236.10K | -234.70K | -283.50K | -308.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 88.52M | 88.52M | 88.52M | 88.40M | 88.17M |
| Average Diluted Shares Outstanding | 88.52M | 88.52M | 88.52M | 88.40M | 88.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |